Canada Pension Plan Investment Board increased its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 16.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,800 shares of the medical instruments supplier’s stock after acquiring an additional 4,600 shares during the period. Canada Pension Plan Investment Board owned about 0.16% of ICU Medical worth $8,991,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of ICUI. Cornerstone Wealth Management LLC acquired a new position in ICU Medical during the 2nd quarter worth about $237,000. Aperio Group LLC lifted its position in ICU Medical by 6.7% during the 2nd quarter. Aperio Group LLC now owns 9,286 shares of the medical instruments supplier’s stock worth $2,727,000 after buying an additional 587 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new position in ICU Medical during the 2nd quarter worth about $3,215,000. Smith Asset Management Group LP lifted its position in ICU Medical by 1,207.6% during the 2nd quarter. Smith Asset Management Group LP now owns 38,745 shares of the medical instruments supplier’s stock worth $11,377,000 after buying an additional 35,782 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in ICU Medical during the 2nd quarter worth about $235,000. 75.97% of the stock is owned by institutional investors.

ICU Medical stock opened at $238.25 on Friday. ICU Medical, Incorporated has a 1 year low of $205.55 and a 1 year high of $321.70. The stock has a market cap of $4.89 billion, a price-to-earnings ratio of 43.16 and a beta of 0.62.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.51 by $0.34. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The company had revenue of $327.20 million for the quarter, compared to the consensus estimate of $334.97 million. During the same period in the prior year, the company posted $1.12 EPS. The company’s revenue was down 4.7% compared to the same quarter last year. Equities research analysts anticipate that ICU Medical, Incorporated will post 7.76 earnings per share for the current year.

In other ICU Medical news, Director Pfizer Inc sold 2,500,000 shares of the company’s stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $209.25, for a total transaction of $523,125,000.00. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 12.50% of the company’s stock.

Several research analysts recently issued reports on ICUI shares. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $337.00 price target on the stock in a research report on Wednesday, August 15th. TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a research report on Monday, August 20th. ValuEngine downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Finally, BidaskClub downgraded shares of ICU Medical from a “strong-buy” rating to a “buy” rating in a research report on Thursday, September 20th.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/12/07/icu-medical-incorporated-icui-shares-bought-by-canada-pension-plan-investment-board.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Read More: How Do You Calculate Return on Investment (ROI)?

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.